dicloabak 1 mg/ml eye drops, solution
laboratoires thea - 1 mg/ml eye drops, solution
zabak 0,25 mg/ml eye drops, solution
laboratoires thea - 0,25 mg/ml eye drops, solution
naclof 0,1% eye drops, solution
laboratoires thea - Диклофенак - 0,1% eye drops, solution
oculotect gel 10,0 mg / g eye gel
laboratoires thea - Ретинол - 10,0 mg / g eye gel
spersadex comp. 5 mg/ml/1 mg/ml eye drops, solution
laboratoires thea - Дексаметазон, Левомицетин - 5 mg/ml/1 mg/ml eye drops, solution
spersallerg 0,5 mg/0,4 mg/ml eye drops, solution
laboratoires thea - tetryzoline, комбинации - 0,5 mg/0,4 mg/ml eye drops, solution
indocollyre 1 mg/ml eye drops, solution
laboratoires chauvin s.a. - Индометацин - 1 mg/ml eye drops, solution
valdoxan
les laboratoires servier - Агомелатин - Депресивно разстройство, майор
thymanax
les laboratoires servier - Агомелатин - Депресивно разстройство, майор
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Антинеопластични средства - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.